Skip to main content
Year archive

NOXOPHARM LIMITED — 2017 filings

All 95 regulatory filings released by NOXOPHARM LIMITED (NOX) in 2017, sourced directly from the official regulator.

95 Filings
2017 Period
2017 filings (95)
Filing Released Lang
KZA: Kazia Therapeutics and Noxopharm 2 pages 391.0KB
Regulatory Filings
2017-12-26 English
Kazia Therapeutics Ltd and Noxopharm Ltd 2 pages 389.9KB
Regulatory Filings
2017-12-26 English
EOY Guidance on 2018 NOX66 Clinical Development Strategy 4 pages 350.1KB
Investor Presentation
2017-12-20 English
Appendix 3B 12 pages 537.9KB
Capital/Financing Update
2017-12-18 English
Section 708 Certificate 1 page 237.4KB
Share Issue/Capital Change
2017-12-18 English
Response to ASX Price Query 5 pages 650.4KB
Regulatory Filings
2017-12-13 English
Appendix 3B 12 pages 538.2KB
Capital/Financing Update
2017-12-11 English
Change of Registered Office 2 pages 234.4KB
Regulatory Filings
2017-12-10 English
Appendix 3B 12 pages 538.2KB
Capital/Financing Update
2017-12-06 English
Section 708 Certificate 1 page 241.3KB
Share Issue/Capital Change
2017-12-06 English
NOX Open Briefing Corporate Presentation 38 pages 9.4MB
Investor Presentation
2017-12-05 English
Compassionate use of NOX66 in Patients 2 pages 251.6KB
Regulatory Filings
2017-12-03 English
Nyrada Inc Opens Capital Raise - Memorandum Released 27 pages 702.9KB
Capital/Financing Update
2017-11-30 English
NYX-104 delivers Key Proof-of-Concept in Stroke Animal Model 3 pages 575.0KB
Capital/Financing Update
2017-11-28 English
Webcast of NOX 2017 AGM 1 page 238.8KB
AGM Information
2017-11-28 English
Appendix 3B 12 pages 536.4KB
Capital/Financing Update
2017-11-28 English
Change of Director's Interest Notice - ID 3 pages 225.2KB
Director's Dealing
2017-11-28 English
Change of Director's Interest Notice - PM 3 pages 225.0KB
Director's Dealing
2017-11-28 English
Invitation to Open Briefing 2 pages 248.9KB
Investor Presentation
2017-11-27 English
AGM Presentations 35 pages 13.0MB
AGM Information
2017-11-26 English
Results of Meeting 3 pages 241.7KB
Declaration of Voting Results & Voting Rights Announcements
2017-11-26 English
Trading Halt 2 pages 460.4KB
Regulatory Filings
2017-11-22 English
Clarification of Incorrect Information 1 page 383.1
Regulatory Filings
2017-11-22 English
NRT: Kazia clarifies media report 2 pages 545.4KB
Regulatory Filings
2017-11-21 English
Completion of Transfer of Shares to Nyrada Inc 2 pages 237.8KB
Capital/Financing Update
2017-11-20 English
NOX 2017 AGM Webcast 1 page 268.7KB
AGM Information
2017-11-20 English
Promising Interim Clinical Data for NOX66 17 pages 1.2MB
Regulatory Filings
2017-11-19 English
Trading Halt 2 pages 460.4KB
Regulatory Filings
2017-11-16 English
1st Patient treated in Lupin Study at St Vincent's Hospital 3 pages 379.6KB
Regulatory Filings
2017-11-15 English
Appendix 3B 11 pages 482.3KB
Capital/Financing Update
2017-11-14 English
Section 708 Certificate 1 page 238.5KB
Share Issue/Capital Change
2017-11-14 English
NOX making three presentations at COSA 5 pages 477.0KB
AGM Information
2017-11-12 English
Appendix 3B 11 pages 481.6KB
Capital/Financing Update
2017-11-06 English
Section 708 Certificate 1 page 238.5KB
Share Issue/Capital Change
2017-11-06 English
EGM Presentations 65 pages 8.2MB
Regulatory Filings
2017-11-05 English
Results of Meeting 2 pages 366.4KB
Declaration of Voting Results & Voting Rights Announcements
2017-11-05 English
UNSW collaboration confirms drug designed for stroke victims 3 pages 341.7KB
AGM Information
2017-11-02 English
Appendix 4C - quarterly 8 pages 619.2KB
Interim / Quarterly Report
2017-10-29 English
Corporate Governance Statement - 2017 13 pages 474.1KB
Governance Information
2017-10-25 English
Corporate Governance Statement - Appendix 4G 12 pages 247.8KB
Regulatory Filings
2017-10-25 English
Annual Report to shareholders 60 pages 1.1MB
Annual Report
2017-10-25 English
Notice of Annual General Meeting/Proxy Form 31 pages 1.4MB
AGM Information
2017-10-25 English
Update - General Meeting Agenda 1 page 322.9KB
AGM Information
2017-10-22 English
October 2017 Open Briefing Corporate Presentation 37 pages 10.8MB
Investor Presentation
2017-10-18 English
Invitation to Open Briefing 2 pages 249.6KB
Regulatory Filings
2017-10-12 English
Establishment of Nyrada Inc. - Extraordinary General Meeting 102 pages 1.7MB
AGM Information
2017-10-03 English
Australian NOX66 - Radiotherapy Study Opens 2 pages 412.7KB
Regulatory Filings
2017-09-26 English
Establishment of Nyrada Inc. 3 pages 488.4KB
Board/Management Information
2017-09-24 English
Positive Clinical Outcomes for NOX66 at ESMO Conference 3 pages 260.2KB
Regulatory Filings
2017-09-11 English
Change in substantial holding 5 pages 157.4KB
Regulatory Filings
2017-09-06 English
Change in substantial holding 3 pages 153.3KB
Major Shareholding Notification
2017-09-05 English
NOX CEO Interview explains recent Brain Cancer Announcement 2 pages 238.9KB
Regulatory Filings
2017-09-03 English
Placement completed App 3B, s708 Notice, LR7.1A4(b) Notice 13 pages 993.3KB
Capital/Financing Update
2017-09-03 English
Corporate Governance Statement 13 pages 474.1KB
Governance Information
2017-08-30 English
Corporate Governance Statement - Appendix 4G 12 pages 503.0KB
Regulatory Filings
2017-08-30 English
Appendix 4E and Audited Financial Statements 47 pages 9.1MB
Regulatory Filings
2017-08-30 English
Important Brain Cancer Findings for NOX66 Program 3 pages 261.2KB
Regulatory Filings
2017-08-28 English
Noxopharm raises $5.5 million to advance clinical program 2 pages 240.2KB
Capital/Financing Update
2017-08-23 English
Reinstatement to Official Quotation 1 page 219.5KB
Regulatory Filings
2017-08-23 English
Suspension from Official Quotation 2 pages 465.7KB
Regulatory Filings
2017-08-22 English
Trading Halt 1 page 252.4KB
Regulatory Filings
2017-08-20 English
Trading Halt Request 1 page 238.7KB
Capital/Financing Update
2017-08-20 English
NOX Corporate Presentation ahead of Conference 24 pages 3.5MB
Investor Presentation
2017-08-07 English
Appendix 4C - quarterly 8 pages 460.7KB
Interim / Quarterly Report
2017-07-30 English
NOX Research Report prepared by APP Securities 2 pages 237.7KB
Investor Presentation
2017-07-26 English
New Corporate Presentation 31 pages 1.5MB
Investor Presentation
2017-07-24 English
CEO Interview with FNN - Singapore and HK Roadshow 2 pages 237.2KB
Regulatory Filings
2017-07-24 English
Noxopharm provides update on NOX66 Clinical Trial Program 5 pages 399.4KB
Regulatory Filings
2017-07-05 English
Idronoxil data provides hope to treat secondary brain cancer 4 pages 263.5KB
Investor Presentation
2017-06-18 English
NOX66 confirmed Non-Toxic. Trial Cleared for Full Enrolment 2 pages 257.6KB
Regulatory Filings
2017-06-04 English
New Corporate Presentation 2 pages 387.2KB
Investor Presentation
2017-05-29 English
St Vincents Cancer Study to Commence-NOX66 and Radiotherapy 3 pages 380.8KB
Regulatory Filings
2017-05-28 English
NOX makes strategic commitment to treatment of rare cancers 3 pages 271.9KB
Capital/Financing Update
2017-05-23 English
Noxopharm Mid Year Investor Briefings 2 pages 250.3KB
Investor Presentation
2017-05-17 English
Market Guidance for Next Six Months 3 pages 254.0KB
Capital/Financing Update
2017-05-01 English
Appendix 4C - quarterly 8 pages 454.9KB
Interim / Quarterly Report
2017-04-26 English
NOX Files Patent Application on 'Smart' Idronoxil 3 pages 257.8KB
Regulatory Filings
2017-04-09 English
FNN Interview with NOX CEO Explaining Idronoxil-C Discovery 2 pages 239.0KB
Regulatory Filings
2017-04-09 English
Appendix 3B 12 pages 477.2KB
Capital/Financing Update
2017-04-02 English
NOX and Monash Uni Collaboration Receives Federal Grant 3 pages 256.9KB
Regulatory Filings
2017-03-26 English
Noxopharm and UNSW combine on stroke project 4 pages 344.4KB
Regulatory Filings
2017-03-15 English
Gold Coast Qld Mid-Year Briefing Details 2 pages 252.1KB
Investor Presentation
2017-03-09 English
Notification of Release of Restricted Securities Escrow 2 pages 328.0KB
Regulatory Filings
2017-03-06 English
NOX researching rare Abscopal Response 3 pages 337.1KB
Capital/Financing Update
2017-03-02 English
NOX Presentation and Interview ASX The CEO Sessions 2 pages 238.1KB
Investor Presentation
2017-02-23 English
Appendix 4D and Half Year Accounts 17 pages 301.4KB
Regulatory Filings
2017-02-23 English
Updated Share Trading Policy 6 pages 430.1KB
Governance Information
2017-02-22 English
ASX CEO Presentation Feb 2017 21 pages 10.2MB
Investor Presentation
2017-02-20 English
Upcoming Events and Presentations 2 pages 238.1KB
Regulatory Filings
2017-02-14 English
Change of Principal Place of Business 2 pages 235.7KB
Regulatory Filings
2017-02-02 English
Brain Cancer Study Commences 3 pages 243.9KB
Regulatory Filings
2017-01-31 English
First NOX66 Clinical Trial to Commence 3 pages 256.3KB
Capital/Financing Update
2017-01-30 English
Appendix 4C - quarterly 7 pages 445.7KB
Interim / Quarterly Report
2017-01-29 English
Appointment of New Company Secretary 2 pages 237.4KB
Board/Management Information
2017-01-15 English
Appendix 3B 13 pages 190.6KB
Share Issue/Capital Change
2017-01-08 English